about
Angiotensin receptor blockers and risk of prostate cancer among United States veteransCardiovascular drugs in the treatment of infantile hemangiomaDo renin-angiotensin system inhibitors influence the recurrence, metastasis, and survival in cancer patients?: Evidence from a meta-analysis including 55 studiesRenin-angiotensin system blockade for the risk of cancer and death.Losartan inhibits collagen I synthesis and improves the distribution and efficacy of nanotherapeutics in tumors.G-protein coupled receptors of the renin-angiotensin system: new targets against breast cancer?Examining the influence of beta blockers and ACE inhibitors on the risk for breast cancer recurrence: results from the LACE cohortAssociations of the Insertion/Deletion Polymorphism in the ACE Gene and Risk of Gastric Cancer: A Meta-Analysis.Angiotensin peptides and lung cancer.Angiotensin system inhibitors and survival outcomes in patients with metastatic renal cell carcinoma.Use of ACE Inhibitors and Angiotensin Receptor Blockers and Primary Breast Cancer OutcomesExposure to ACEI/ARB and β-Blockers Is Associated with Improved Survival and Decreased Tumor Progression and Hospitalizations in Patients with Advanced Colon Cancer.Comparative safety of cardiovascular medication use and breast cancer outcomes among women with early stage breast cancer.Angiotensin inhibition and longevity: a question of hydration.Association of angiotensin I converting enzyme insertion/deletion polymorphism with breast cancer: a meta-analysis.Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in cancer progression and survival: a systematic review.Critical review of cancer risk associated with angiotensin receptor blocker therapy.Angiotensin-(1-7) reduces proliferation and angiogenesis of human prostate cancer xenografts with a decrease in angiogenic factors and an increase in sFlt-1.Cell signaling, internalization, and nuclear localization of the angiotensin converting enzyme in smooth muscle and endothelial cells.Use of antihypertensive drugs and risk of skin cancer.Lack of association of genetic polymorphisms of angiotensin converting enzyme 1 and angiotensin II type 1 receptor with breast cancer risk in Iranian population.Liver Protective Effects of Renin-Angiotensin System Inhibition Have No Survival Benefits in Hepatocellular Carcinoma Induced By Repetitive Administration of Diethylnitrosamine in Mice.
P2860
Q24626548-FEC5622D-9AB9-4FB3-9A82-A5D51125D8AAQ26769978-7965EEAC-2B84-4F6C-A74D-410B4E520847Q30235047-7C739D55-02E3-42C4-9D01-05AC62AF048DQ30249043-BA9D806A-C87E-41F6-A0E0-868520D9F684Q34582878-2A12F53D-1B66-44A1-9773-7F77766A101EQ35089791-5EBE15F6-19FD-4FE2-A721-529C35C2CF5BQ35131970-5C23C65C-1E16-4093-850F-536C74AF25B8Q35755375-093706C3-0FE8-4D56-A69A-9BBE9C87AFE8Q35857462-9F94A960-E24E-44AB-A389-55B89B03DA4DQ36051199-385C959D-A3F1-4FC3-B8FD-541424C328E3Q37121758-E830AD55-8D89-4708-B2D5-73A3824D7201Q37236007-A275C77C-D16F-4EC3-A15C-8DBEFECA46B9Q37705334-76A8234E-1685-4914-A853-1AF8BAB5115EQ37821796-3F545BF5-5B16-417D-9E3A-FB0403175497Q37872496-62FF4867-DB04-48E4-B038-D14DD61600DBQ37960818-A5A7DE0C-5D46-4DD7-B112-67F19F1B9F97Q37975493-B30061A3-F24B-4C75-8CFC-7950F7440475Q39340234-9CECA13D-1551-4DCB-AB88-029279D1E87DQ39761326-73710F5E-B471-4294-AF50-C9959EC50834Q42472270-F988655A-ABCF-4D2A-AFE7-13D0A3B6CBC0Q50969065-E5989CEB-B0BC-45F4-9559-F82C4BA60542Q55426501-CDEB6E94-45C8-4A61-B916-99BA7ADDB35B
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 02 April 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Angiotensin inhibition and malignancies: a review.
@en
Angiotensin inhibition and malignancies: a review.
@nl
type
label
Angiotensin inhibition and malignancies: a review.
@en
Angiotensin inhibition and malignancies: a review.
@nl
prefLabel
Angiotensin inhibition and malignancies: a review.
@en
Angiotensin inhibition and malignancies: a review.
@nl
P2860
P356
P1476
Angiotensin inhibition and malignancies: a review
@en
P2093
T Rosenthal
P2860
P2888
P304
P356
10.1038/JHH.2009.21
P50
P577
2009-04-02T00:00:00Z